Xenon Pharmaceuticals Inc.
XENE | NASDAQ
$37.94
+$0.53 (+1.42%)
Nov 2, 2026, 12:48 PM ET · Market open
Market Data
Market Cap $3.67B
Enterprise Value $2.7B
Beta 0.60
Average Volume 1.52M
Shares Outstanding (Diluted) 99.61M
Shares Change YoY 26.16%
Institutional Ownership N/A
Exchange NASDAQ
ISIN CA98420N1050
Price Performance
Price Change 1M -0.2%
Price Change 3M -39.1%
Price Change 6M -33.9%
Price Change YTD -15.3%
Price Change 1Y -7.7%
Price Change 3Y 15.4%
Price Change 5Y 11.3%
1M CAGR (ann.) -5.9%
1Y CAGR (ann.) -11.6%
5Y CAGR (ann.) 3.9%
All-Time CAGR 17.3%
Valuation
PE Ratio -7.89
Forward PE N/A
PEG Ratio 0.29
Forward PEG -0.94
PS Ratio N/A
Forward PS 125.30
PB Ratio 2.92
P/FCF Ratio -10.70
P/Adj. FCF Ratio -9.06
P/OCF Ratio -11.04
EV/Sales N/A
EV/EBIT -6.45
EV/EBITDA -6.48
EV/FCF -7.97
Earnings Yield -12.7%
FCF Yield -9.3%
Adj. FCF Yield -11.0%
Financial Health
Net Cash $929.35M
Total Debt $6.42M
Cash & Short-Term Investments $930.69M
Total Assets $1.3B
Current Ratio 21.02
Quick Ratio 21.02
Debt / Equity Ratio 0.01
Debt / EBITDA -0.02
Debt / FCF -0.02
OCF / Debt -52.59
Interest Coverage 0.00
Altman Z-Score 38.92
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -18.1%
Returns
Return on Assets -31.6%
Return on Equity -44.0%
Return on Invested Capital -35.1%
Return on Capital Employed -35.3%
Return on Tangible Assets -31.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 0.0%
Revenue CAGR 5Y -60.7%
Revenue CAGR 10Y -4.9%
EPS CAGR 3Y -27.2%
EPS CAGR 5Y -21.9%
EPS CAGR 10Y -13.7%
FCF CAGR 3Y -36.8%
FCF CAGR 5Y -33.3%
FCF CAGR 10Y -28.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 8
EPS Growth Next 3Y 35.6%
Revenue Growth Next 3Y N/A
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$1.13
EPS Growth Est (next Q) -1.7%
Revenue Est (next Q) $1.33M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $68.63
Price Target Upside 83.5%
Cash Flow
Operating Cash Flow $-337.52M
Free Cash Flow $-338.53M
Adj. Free Cash Flow $-399.97M
FCF Per Share -$3.40
OCF Per Share -$3.39
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-77.67M
Operating Income $-441.59M
EBITDA $-416.75M
Net Income $-409.2M
EPS (Diluted) -$4.74
Revenue / Employee N/A
Profit / Employee $-1.12M
Employees 364
Add to Watchlist
Select watchlists to add or remove XENE